Hypoactive sexual desire disorder: inventing a disease to sell low libido.
about
First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.Flibanserin and its discontents.CME stands for commercial medical education: and ACCME still won't address the issueThe unethical use of ethical rhetoric: the case of flibanserin and pharmacologisation of female sexual desire.Accreditation rules safeguard continuing medical education from commercial influence.Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.
P2860
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@ast
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@en
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@nl
type
label
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@ast
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@en
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@nl
prefLabel
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@ast
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@en
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@nl
P2093
P2860
P1476
Hypoactive sexual desire disorder: inventing a disease to sell low libido.
@en
P2093
Adriane Fugh-Berman
Antonie Meixel
Elena Yanchar
P2860
P304
P356
10.1136/MEDETHICS-2014-102596
P577
2015-06-29T00:00:00Z